Skip to main content

Table 1 Baseline patients' characteristics used in the discovery phase

From: Urinary alpha-1 antitrypsin and CD59 glycoprotein predict albuminuria development in hypertensive patients under chronic renin-angiotensin system suppression

 

N (n = 5)

dnHA (n = 5)

MHA (n = 5)

P value

Age (years)

58 ± 7

58 ± 7

62 ± 5

0.463

Sex (male), %

60

60

60

>0.999

BMI (kg/m2)

30 ± 3

29 ± 1

28 ± 4

0.650

Current smoking, %

0

40

20

0.725

Total cholesterol (mg/dl)

188 ± 32

157 ± 15

175 ± 18

0.159

Triglycerides (mg/dl)

114 ± 43

112 ± 68

90 ± 27

0.765

HDL cholesterol (mg/dl)

49 ± 12

51 ± 23

58 ± 12

0.497

LDL cholesterol (mg/dl)

116 ± 34

83 ± 13

99 ± 12

0.150

Glycaemic (mg/dl)

91 ± 11

101 ± 7

92 ± 8

0.190

Uric acid (mg/dl)

5.6 ± 1.7

6.1 ± 1.8

4.6 ± 1.2

0.330

Creatinine clearance rate (mg/ml)

87 ± 24

112 ± 61

89 ± 28

0.876

eGFR (ml/min/1.73 m2)

83 ± 10

87 ± 28

88 ± 17

0.536

Systolic blood pressure (mmHg)

132 ± 16

138 ± 8

126 ± 15

0.390

Diastolic blood pressure (mmHg)

84 ± 14

83 ± 10

81 ± 7

0.869

ACR (mg/g)

3.8 ± 1.7

74 ± 33

75 ± 90

0.001

Diabetes mellitus, %

0

0

0

>0.999

  1. Values expressed as mean ± SD or percentages (%)
  2. BMI body mass index, HDL high-density lipoprotein cholesterol, LDL low-density lipoprotein cholesterol, N normoalbuminuria, dnHA de novo high albuminuria, MHA maintained high albuminuria